1-7 of 7
Tim Eisen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma

Andrew J. Armstrong, Andrew B. Nixon, Andrea Carmack, Qian Yang, Tim Eisen, Walter M. Stadler, Robert J. Jones, Jorge A. Garcia, Ulka N. Vaishampayan, Joel Picus, Robert E. Hawkins, John D. Hainsworth, Christian K. Kollmannsberger, Theodore F. Logan, Igor Puzanov, Lisa M. Pickering, Christopher W. Ryan, Andrew Protheroe, Daniel J. George, Susan Halabi
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (12): 3503.
https://doi.org/10.1158/1078-0432.CCR-21-1636
Published: 15 June 2021
View article titled, Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma
Open the PDF for Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma in another window
Journal Articles

Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma

Andrew J. Armstrong, Andrew B. Nixon, Andrea Carmack, Qian Yang, Tim Eisen, Walter M. Stadler, Robert J. Jones, Jorge A. Garcia, Ulka N. Vaishampayan, Joel Picus, Robert E. Hawkins, John D. Hainsworth, Christian K. Kollmannsberger, Theodore F. Logan, Igor Puzanov, Lisa M. Pickering, Christopher W. Ryan, Andrew Protheroe, Daniel J. George, Susan Halabi
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (12): 3317–3328.
https://doi.org/10.1158/1078-0432.CCR-20-4504
Published: 15 June 2021
View article titled, Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma
Open the PDF for Angiokines Associated with Targeted Therapy Outcomes in Patients with Non–Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

Xiaoyan Liu, Jesse J. Swen, Meta H.M. Diekstra, Epie Boven, Daniel Castellano, Hans Gelderblom, Ron H.J. Mathijssen, Sita H. Vermeulen, Egbert Oosterwijk, Kerstin Junker, Max Roessler, Kristin Alexiusdottir, Asgerdur Sverrisdottir, Marius T. Radu, Valentin Ambert, Tim Eisen, Anne Warren, Cristina Rodríguez-Antona, Jesus García-Donas, Stefan Böhringer, Karel K.M. Koudijs, Lambertus A.L.M. Kiemeney, Brian I. Rini, Henk-Jan Guchelaar
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (10): 2350–2356.
https://doi.org/10.1158/1078-0432.CCR-17-2815
Published: 14 May 2018
View article titled, A Genetic Polymorphism in <em>CTLA-4</em> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma
Open the PDF for A Genetic Polymorphism in <em>CTLA-4</em> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group

Judith Manola, Patrick Royston, Paul Elson, Jennifer Bacik McCormack, Madhu Mazumdar, Sylvie Négrier, Bernard Escudier, Tim Eisen, Janice Dutcher, Michael Atkins, Daniel Y.C. Heng, Toni K. Choueiri, Robert Motzer, Ronald Bukowski
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5443–5450.
https://doi.org/10.1158/1078-0432.CCR-11-0553
Published: 14 August 2011
View article titled, Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
Open the PDF for Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group in another window
Includes: Supplementary data
Journal Articles

Targeting Multiple Kinase Pathways: A Change In Paradigm

Lucy Gossage, Tim Eisen
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7): 1973–1978.
https://doi.org/10.1158/1078-0432.CCR-09-3182
Published: 31 March 2010
View article titled, Targeting Multiple Kinase Pathways: A Change In Paradigm
Open the PDF for Targeting Multiple Kinase Pathways: A Change In Paradigm in another window
Journal Articles

Her2-Targeted Therapies in Non–Small Cell Lung Cancer

Charles Swanton, Andy Futreal, Tim Eisen
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4377s–4383s.
https://doi.org/10.1158/1078-0432.CCR-06-0115
Published: 20 July 2006
View article titled, Her2-Targeted Therapies in Non–Small Cell Lung Cancer
Open the PDF for Her2-Targeted Therapies in Non–Small Cell Lung Cancer in another window
Journal Articles

Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma

Tanya Ahmad, Tim Eisen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6388S–6392S.
https://doi.org/10.1158/1078-0432.CCR-040028
Published: 15 September 2004
View article titled, Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma
Open the PDF for Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma in another window